Surzebiclimab
Clivatuzumab
Gatipotuzumab
Minretumomab
Sontuzumab
Ensituximab
MUC1, mucin core
MUC5AC motif peptide
Ac5GalNTGc
Ac5GalNTGc epimer
Tasuldine
Eudragit RS 100
Gefarnate
Guaifenesin